Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Receivables: 2018-2024

Historic Change in Receivables for Sunshine Biopharma (SBFM) over the last 7 years, with Dec 2024 value amounting to $2.3 million.

  • Sunshine Biopharma's Change in Receivables rose 165.84% to $649,850 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 34.64%. This contributed to the annual value of $2.3 million for FY2024, which is 293.54% up from last year.
  • According to the latest figures from FY2024, Sunshine Biopharma's Change in Receivables is $2.3 million, which was up 293.54% from $594,141 recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Change in Receivables registered a high of $2.3 million during FY2024, and its lowest value of $1,486 during FY2020.
  • In the last 3 years, Sunshine Biopharma's Change in Receivables had a median value of $594,141 in 2023 and averaged $1.2 million.
  • Data for Sunshine Biopharma's Change in Receivables shows a peak YoY surged of 8,816.80% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Change in Receivables stood at $1,486 in 2020, then soared by 295.83% to $5,882 in 2021, then surged by 8,816.80% to $524,486 in 2022, then grew by 13.28% to $594,141 in 2023, then spiked by 293.54% to $2.3 million in 2024.